MetLife (NYSE: MET) investors back directors, Deloitte auditor and 2026 executive pay

Rhea-AI Filing Summary

MetLife, Inc. shareholders held their annual meeting on June 16, 2026. Investors elected eleven directors to terms expiring at the 2027 annual meeting, with each nominee receiving a large majority of votes cast. Shareholders also ratified Deloitte & Touche LLP as MetLife’s independent auditor for 2026.

In addition, shareholders approved on an advisory (non-binding) basis the compensation paid to MetLife’s Named Executive Officers, as described in the 2026 proxy statement. Overall, the voting results indicate broad shareholder support for the company’s board, executive pay program, and external auditor.

8-K Event Classification

Item 5.07 — Submission of Matters to a Vote of Security Holders

1 item

Item 5.07 Submission of Matters to a Vote of Security Holders Governance

Results of a shareholder vote on proposals at an annual or special meeting.

Key Figures

Directors elected: 11 directors Votes for Deloitte & Touche LLP: 557,226,053 votes Votes against Deloitte & Touche LLP: 34,799,734 votes +5 more

8 metrics

Directors elected 11 directors Elected at annual meeting, terms expiring at 2027 meeting

Votes for Deloitte & Touche LLP 557,226,053 votes Ratification as independent auditor for 2026

Votes against Deloitte & Touche LLP 34,799,734 votes Ratification as independent auditor for 2026

Say-on-pay votes for 519,208,384 votes Advisory approval of Named Executive Officers’ compensation

Say-on-pay votes against 29,698,510 votes Advisory approval of Named Executive Officers’ compensation

Broker non-votes on say-on-pay 42,002,376 votes Advisory vote on executive compensation

Votes for Michel A. Khalaf 548,618,537 votes Election as director

Votes for Daniel S. Glaser 548,594,293 votes Election as director

Key Terms

Broker Non-Votes, advisory (non-binding) vote, Named Executive Officers, independent auditor, +1 more

5 terms

Broker Non-Votes financial

"Nominee Name | Votes For | Votes Against | Abstained | Broker Non-Votes"

Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

advisory (non-binding) vote financial

"Advisory (non-binding) vote to approve the compensation paid"

Named Executive Officers financial

"the compensation paid to the Company’s Named Executive Officers"

Named executive officers are the senior company leaders whose names, roles and compensation are singled out in required regulatory filings; this typically includes the chief executive, chief financial officer and the next highest‑paid senior officers. Investors treat this list like a team roster — it shows who makes key decisions, how they are paid and whether incentives align with shareholder interests, so changes or pay patterns can signal governance quality, risk or strategic shifts.

independent auditor financial

"Independent Auditor for 2026"

An independent auditor is an outside, qualified accounting professional or firm that examines a company's financial records and controls to determine whether its financial statements are accurate and prepared according to accepted accounting rules. Like a neutral referee or home inspector, the auditor issues a report that gives investors confidence (or raises red flags) about the reliability of the numbers, which affects assessments of risk, valuation and investment decisions.

annual meeting of common shareholders financial

"at the Company’s annual meeting of common shareholders on June 16, 2026"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Understanding 8-K Material Events →

0001099219false00010992192026-06-162026-06-160001099219us-gaap:CommonStockMember2026-06-162026-06-160001099219us-gaap:SeriesAPreferredStockMember2026-06-162026-06-160001099219us-gaap:SeriesEPreferredStockMember2026-06-162026-06-160001099219us-gaap:SeriesFPreferredStockMember2026-06-162026-06-16

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549  

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): June 16, 2026

METLIFE, INC.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

(State or Other Jurisdiction of Incorporation)

1-15787

13-4075851

(Commission File Number)

(IRS Employer Identification No.)

200 Park Avenue,

New York,

NY

10166-0188

(Address of Principal Executive Offices)

(Zip Code)

(212) 578-9500

(Registrant’s Telephone Number, Including Area Code)

N/A

(Former Name or Former Address, if Changed Since Last Report) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01			MET			New York Stock Exchange
Floating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01			MET PRA			New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series E			MET PRE			New York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series F			MET PRF			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

Item 5.07 Submission of Matters to a Vote of Security Holders.

At MetLife, Inc.’s (the “Company’s”) annual meeting of common shareholders on June 16, 2026, the shareholders:

•elected eleven Directors, each for a term expiring at the Company’s 2027 annual meeting of shareholders;

•ratified the appointment of Deloitte & Touche LLP as the Company’s independent auditor for 2026; and

•approved, on an advisory (non-binding) basis, the compensation paid to the Company’s Named Executive Officers as disclosed in the Company’s 2026 Proxy Statement.

Election of Directors:

Nominee Name			Votes For			Votes Against			Abstained			Broker Non-Votes
Daniel S. Glaser			548,594,293			1,402,406			301,946			42,002,376
Carla A. Harris			531,093,856			18,882,222			322,567			42,002,376
Laura J. Hay			546,736,903			3,260,345			301,397			42,002,376
R. Glenn Hubbard, Ph.D.			527,371,205			22,608,371			319,069			42,002,376
Jeh C. Johnson			540,643,747			9,327,414			327,484			42,002,376
William E. Kennard			542,209,127			7,782,975			306,543			42,002,376
Michel A. Khalaf			548,618,537			1,357,430			322,678			42,002,376
Diana L. McKenzie			547,213,102			2,800,742			284,801			42,002,376
Christian S. Mumenthaler, Ph.D.			548,665,228			1,315,288			318,129			42,002,376
Michelle Seitz			548,256,661			1,742,224			299,760			42,002,376
Mark A. Weinberger			531,174,670			18,815,797			308,178			42,002,376

			Votes For			Votes Against			Abstained			Broker Non-Votes
Ratification of appointment of Deloitte & Touche LLP as the Company’s Independent Auditor for 2026			557,226,053			34,799,734			275,234			N/A
Advisory (non-binding) vote to approve the compensation paid to the Company’s Named Executive Officers			519,208,384			29,698,510			1,391,751			42,002,376

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

METLIFE, INC.

By:

/s/ Timothy J. Ring

Name:

Timothy J. Ring

Title:

Senior Vice President and Secretary

Date: June 22, 2026

3

FAQ

What did MetLife (MET) shareholders approve at the June 16, 2026 annual meeting?

Shareholders approved the election of eleven directors, ratified Deloitte & Touche LLP as the 2026 independent auditor, and backed executive compensation on an advisory basis. These results indicate broad support for MetLife’s governance, audit choice, and pay practices.

How many directors were elected at MetLife’s 2026 annual meeting and for how long?

Shareholders elected eleven directors, each to a term expiring at the 2027 annual meeting of shareholders. This confirms the full board slate presented in MetLife’s 2026 proxy statement, with each nominee receiving strong support in the voting results disclosed.

Did MetLife (MET) shareholders ratify Deloitte & Touche LLP as the 2026 auditor?

Yes. Shareholders ratified Deloitte & Touche LLP as MetLife’s independent auditor for 2026 with 557,226,053 votes for, 34,799,734 against, and 275,234 abstentions. This confirms Deloitte’s continued role as the company’s external audit firm.

How did MetLife shareholders vote on executive compensation in 2026?

MetLife shareholders approved, on an advisory non-binding basis, compensation for the company’s Named Executive Officers. The vote totaled 519,208,384 for, 29,698,510 against, and 1,391,751 abstentions, plus 42,002,376 broker non-votes, signaling strong support for the disclosed pay program.

Which MetLife director nominees received the highest shareholder support in 2026?

Several nominees received strong support, including Michel A. Khalaf with 548,618,537 votes for and Christian S. Mumenthaler with 548,665,228 votes for. All eleven nominees were elected, showing broad backing for MetLife’s proposed board slate at the 2026 meeting.

What were broker non-votes in MetLife’s 2026 shareholder meeting results?

Broker non-votes totaled 42,002,376 on the director elections and the advisory vote on executive compensation. Broker non-votes occur when brokers hold shares but are not instructed how to vote on certain proposals that require explicit shareholder direction.

Filing Exhibits & Attachments

4 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2.2 KB
• EX-101 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT 16.2 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT 28.5 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT 16.9 KB